UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Equinix
EQIX
|
+$1.32B |
| 2 |
Digital Realty Trust
DLR
|
+$931M |
| 3 |
Western Digital
WDC
|
+$895M |
| 4 |
Simon Property Group
SPG
|
+$736M |
| 5 |
Realty Income
O
|
+$643M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$1.73B |
| 2 |
Eaton
ETN
|
+$1.21B |
| 3 |
Seagate
STX
|
+$1.1B |
| 4 |
Trane Technologies
TT
|
+$1.02B |
| 5 |
Accenture
ACN
|
+$1.01B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 40.05% |
| 2 | Financials | 11.12% |
| 3 | Healthcare | 9.54% |
| 4 | Consumer Discretionary | 9.09% |
| 5 | Communication Services | 8.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1626
Century Aluminum
CENX
$3.3B
| $4.61M | ﹤0.01% |
100,220
+3,903
| +4% | +$235K |
2013 Q2
52 quarters
|
|
1627
PDF Solutions
PDFS
$1.87B
| $4.6M | ﹤0.01% |
65,049
+5,210
| +9% | +$258K |
2017 Q2
36 quarters
|
|
1628
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$51.2B
| $4.6M | ﹤0.01% |
50,171
| – | – |
2025 Q4
2 quarters
|
|
1629
Werner Enterprises
WERN
$1.76B
| $4.55M | ﹤0.01% |
104,230
+5,490
| +6% | +$207K |
2013 Q2
52 quarters
|
|
1630
State Street Health Care Select Sector SPDR ETF
XLV
$47.1B
| $4.54M | ﹤0.01% |
28,630
-175,721
| -86% | -$26.1M |
2025 Q4
2 quarters
|
|
1631
O-I Glass
OI
$988M
| $4.53M | ﹤0.01% |
470,229
+170,764
| +57% | +$1.61M |
2013 Q2
52 quarters
|
|
1632
GRAIL Inc
GRAL
$6.73B
| $4.51M | ﹤0.01% |
66,077
+9,094
| +16% | +$535K |
2024 Q2
8 quarters
|
|
1633
Atour Lifestyle Holdings
ATAT
$4.46B
| $4.5M | ﹤0.01% |
141,473
+83,321
| +143% | +$2.98M |
2024 Q3
7 quarters
|
|
1634
St. Joe Company
JOE
$3.87B
| $4.47M | ﹤0.01% |
71,361
-9,192
| -11% | -$603K |
2013 Q2
52 quarters
|
|
1635
City Holding Co
CHCO
$1.99B
| $4.47M | ﹤0.01% |
33,671
+6,314
| +23% | +$793K |
2014 Q1
49 quarters
|
|
1636
Loar Holdings
LOAR
$5.75B
| $4.46M | ﹤0.01% |
55,297
-3,799
| -6% | -$242K |
2025 Q1
5 quarters
|
|
1637
Peloton Interactive
PTON
$2.33B
| $4.46M | ﹤0.01% |
754,158
-1,068,976
| -59% | -$5.77M |
2020 Q2
24 quarters
|
|
1638
Prestige Consumer Healthcare
PBH
$2.25B
| $4.45M | ﹤0.01% |
94,148
-5,103
| -5% | -$262K |
2013 Q2
52 quarters
|
|
1639
Immunovant
IMVT
$5.97B
| $4.43M | ﹤0.01% |
115,102
-26,626
| -19% | -$811K |
2020 Q2
24 quarters
|
|
1640
JPMorgan International Growth ETF
JIG
$526M
| $4.4M | ﹤0.01% |
50,474
| – | – |
2026 Q1
1 quarter
|
|
1641
Alkami Technology
ALKT
$1.64B
| $4.4M | ﹤0.01% |
242,763
+113,390
| +88% | +$1.87M |
2023 Q3
11 quarters
|
|
1642
Apollo Commercial Real Estate
ARI
$847M
| $4.39M | ﹤0.01% |
411,379
+68,965
| +20% | +$751K |
2013 Q2
52 quarters
|
|
1643
State Street Industrial Select Sector SPDR ETF
XLI
$30.9B
| $4.39M | ﹤0.01% |
23,704
-166,371
| -88% | -$28.9M |
2025 Q4
2 quarters
|
|
1644
Douglas Dynamics
PLOW
$916M
| $4.39M | ﹤0.01% |
81,335
+3,472
| +4% | +$160K |
2013 Q2
52 quarters
|
|
1645
PROG Holdings
PRG
$1.18B
| $4.37M | ﹤0.01% |
93,734
-387
| -0.4% | -$13.5K |
2020 Q4
22 quarters
|
|
1646
Intuitive Machines
LUNR
$1.87B
| $4.36M | ﹤0.01% |
203,818
-989
| -0.5% | -$27.8K |
2025 Q1
5 quarters
|
|
1647
Clover Health Investments
CLOV
$2.46B
| $4.36M | ﹤0.01% |
831,748
+149,953
| +22% | +$509K |
2024 Q3
7 quarters
|
|
1648
Astronics
ATRO
$2.61B
| $4.36M | ﹤0.01% |
53,627
-5,106
| -9% | -$349K |
2024 Q2
8 quarters
|
|
1649
SoundHound AI
SOUN
$1.94B
| $4.35M | ﹤0.01% |
672,929
+30,174
| +5% | +$234K |
2023 Q3
11 quarters
|
|
1650
Central Garden & Pet Co Class A
CENTA
$2.43B
| $4.34M | ﹤0.01% |
112,005
-2,777
| -2% | -$96.9K |
2013 Q2
52 quarters
|
|
Similar funds
UBS AM's Q2 2026 Portfolio in Review
As of Q2 2026, UBS AM held 3,886 positions worth $550B, up 14% from $481B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
UBS AM's Q2 2026 filing shows 45 new, 996 increased, 1,636 reduced and 163 closed positions. Its largest new stake was Honeywell Aerospace: 1,676,062 shares worth $371M. The largest sale was Linde, an estimated $1.73B.
By sector, the portfolio is most concentrated in Technology at 40% of assets, up from 35% a quarter earlier, followed by Financials and Healthcare.
- UBS AM's largest Q2 2026 buy was Honeywell Aerospace: 1,676,062 shares worth $371M.
- UBS AM added most to Equinix in Q2 2026, an estimated $1.32B increase.
- UBS AM's biggest Q2 2026 reduction was Linde, cutting an estimated $1.73B.
- UBS AM fully exited Hologic in Q2 2026, selling an estimated $174M.
- UBS AM's ten largest holdings make up 33% of its $550B portfolio in Q2 2026.
- UBS AM opened 45 new positions and closed 163 in Q2 2026.
- UBS AM's portfolio value rose 14% quarter-over-quarter to $550B.
Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.